ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ALTH Allos Therapeutics, Inc. (MM)

1.83
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Allos Therapeutics, Inc. (MM) NASDAQ:ALTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.83 0 01:00:00

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

09/07/2012 12:03pm

Dow Jones News


Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Allos Therapeutics, Inc. (MM) Charts.

Among the companies with shares expected to actively trade in Monday's session is Box Ships Inc. (TEU).

Box Ships said it is withdrawing its public offering of 700,000 units, which was part of an effort to finance the acquisition of two containerships. Shares were off 4.5% to $8.03 after hours.

Watchlist:

AT&T Inc. (T) said about 7,000 core wireline employees have failed to ratify a one-year contract extension and said it will continue to work with their union to reach an agreement.

Spectrum Pharmaceuticals Inc. (SPPI) has again extended its tender offer for fellow biopharmaceutical company Allos Therapeutics Inc. (ALTH), so that the companies can continue cooperating with the Federal Trade Commission. It also said the European Commission has recommended against the approval of Allos's peripheral T-cell lymphoma treatment Folotyn.

Stryker Corp. (SYK) has voluntarily recalled two metal devices used in hip implant surgeries, citing risks associated with fretting and corrosion.

Yahoo Inc. (YHOO) and Facebook Inc. (FB) have reached a settlement ending patent litigation between the firms, drawing an end to a nasty but ultimately short-lived dispute that had roiled Silicon Valley. The agreement is intended to further expand partnership ties between the firms that predate the litigation, and doesn't involve any payments.

Write to Nathalie Tadena at nathalie.tadena@dowjones.com

1 Year Allos Therapeutics, Inc. (MM) Chart

1 Year Allos Therapeutics, Inc. (MM) Chart

1 Month Allos Therapeutics, Inc. (MM) Chart

1 Month Allos Therapeutics, Inc. (MM) Chart